About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Early Diagnosis and Treatment of Type 2 Diabetes Reduces Risk of Heart Disease, Death

by Shirley Johanna on May 20, 2015 at 3:03 PM
Early Diagnosis and Treatment of Type 2 Diabetes Reduces Risk of Heart Disease, Death

The early detection of Type 2 diabetes followed by early treatment can reduce the risk of heart disease and death, says a new research.

In a study conducted at the University of Michigan Medical School and the University of Cambridge, it was analyzed that the early screening of Type 2 diabetes could lead to substantial health benefits. This approach revealed that screening followed by treatment led to a reduced risk of cardiovascular disease or death within a five-year follow-up period when compared to patients having no screening.

Advertisement

Professor William Herman of the University of Michigan said the research showed early identification of diabetes had major health benefits, and supported the introduction of measures such as screening so as to reduce the time between development of Type 2 diabetes and its treatment.

At 10 years after baseline, the simulations predicted that with a delay of three years in diagnosis and treatment, 22.4 percent of those with Type 2 diabetes would experience a cardiovascular disease event, such as stroke or heart bypass surgery. This rose to 25.9 percent with a diagnosis delay of six years.
Advertisement

However, if screening and routine care had been implemented, the simulation predicted only 18.4 percent would experience a cardiovascular disease event at 10 years after baseline. The simulated incidence of all-cause mortality was 16.4 percent with a delay of three years and 18.2 percent with a delay of six years, compared to 14.6 percent for screening and treatment.

This means that over 10 years, the model predicts that for people with undiagnosed Type 2 diabetes, screening would be associated with a 29 percent reduction in relative risk of a cardiovascular disease event, compared with a delay of six years in diagnosis and treatment.

This amounts to a 7.5 percent reduction in the absolute risk of adverse cardiovascular outcome in this population. The comparable change in all-cause mortality was 20 percent relative risk and 3.6 percent absolute risk reduction.

The research is published in Diabetes Care.

Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Diabetes News

Mastering Blood Sugar and Weight Loss
Recent study underscores tirzepatide's supremacy over semaglutide in regulating blood sugar and achieving weight loss.
Time Your Physical Activity Well to Stay Out of Diabetes
Physical activity or exercise in the morning and afternoon reduces type 2 diabetes risk, whereas evening exercise has no such association.
Staying Late at Night? Late Morning Wake-up? Your Chance of Diabetes may be High
Late sleepers and late risers may both have a higher risk of developing diabetes.
New Hope for Type 1 Diabetes: Semaglutide Reduces Insulin Dependency
Semaglutide, the anti-diabetic drug operating by stimulating insulin secretion, might have the potential to supplant the need for mealtime insulin injections.
Bacteria Treatment Shows Potential Against Insulin Resistance & Diabetes
The gut bacteria known as Lachnospiraceae might have the ability to boost insulin sensitivity, potentially providing a protective barrier against diabetes.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Early Diagnosis and Treatment of Type 2 Diabetes Reduces Risk of Heart Disease, Death Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests